1. Home
  2. ASMB vs YSXT Comparison

ASMB vs YSXT Comparison

Compare ASMB & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$23.42

Market Cap

442.9M

Sector

Health Care

ML Signal

HOLD

Logo YSX Tech. Co. Ltd Class A Ordinary Shares

YSXT

YSX Tech. Co. Ltd Class A Ordinary Shares

HOLD

Current Price

$1.20

Market Cap

29.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
YSXT
Founded
2005
2011
Country
United States
China
Employees
N/A
39
Industry
Biotechnology: Pharmaceutical Preparations
Automotive Aftermarket
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
442.9M
29.0M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
ASMB
YSXT
Price
$23.42
$1.20
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$44.20
N/A
AVG Volume (30 Days)
188.1K
12.0K
Earning Date
05-06-2026
02-03-2026
Dividend Yield
N/A
N/A
EPS Growth
91.78
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$638.39
N/A
P/E Ratio
N/A
$5.57
Revenue Growth
N/A
N/A
52 Week Low
$16.80
$0.93
52 Week High
$39.71
$5.96

Technical Indicators

Market Signals
Indicator
ASMB
YSXT
Relative Strength Index (RSI) 37.40 69.04
Support Level $20.23 $1.06
Resistance Level $30.80 $1.31
Average True Range (ATR) 1.50 0.06
MACD -0.32 0.02
Stochastic Oscillator 22.81 79.31

Price Performance

Historical Comparison
ASMB
YSXT

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares

YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.

Share on Social Networks: